Immucell (ICCC) EBITDA Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Immucell (ICCC) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 360.00 |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 2.00 |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 6,666.00 |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 282.00 |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 6,385.00 |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,385.00 |
| Dec 31, 2025 | 4,101.00 |
| Sep 30, 2025 | 1,323.00 |
| Jun 30, 2025 | 2,487.00 |
| Mar 31, 2025 | 434.00 |
| Dec 31, 2024 | 535.00 |
| Sep 30, 2024 | -1,483.00 |
| Jun 30, 2024 | -3,008.00 |
| Mar 31, 2024 | 499.00 |
| Sep 30, 2023 | -1,518.00 |
| Jun 30, 2023 | -1,362.00 |
| Mar 31, 2023 | -6,947.00 |
| Dec 31, 2022 | -3,510.00 |
| Sep 30, 2022 | 161.00 |
| Jun 30, 2022 | 415.00 |
| Mar 31, 2022 | 350.00 |
| Dec 31, 2021 | 3,420.00 |
| Sep 30, 2021 | 1,219.00 |
| Jun 30, 2021 | 1,116.00 |
| Mar 31, 2021 | -294.00 |